How to get Wellbutrin fast in New York

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can access treatment from the comfort of your home. The short answer is yes—telehealth has opened new pathways for people seeking help for BED, including prescription medications. But navigating the rules, understanding what’s available, and knowing what to expect can feel overwhelming.

This comprehensive guide will walk you through everything you need to know about getting binge eating disorder medication online in 2026, including federal and state regulations, which medications are available, who can prescribe them, and how to access safe, effective care.

Understanding Binge Eating Disorder and Why Treatment Matters

Binge eating disorder is the most common eating disorder in the United States, affecting millions of people. It’s characterized by recurrent episodes of eating large amounts of food in a short period—typically within two hours—accompanied by a feeling of loss of control. Unlike bulimia, BED doesn’t involve purging behaviors.

According to the DSM-5 diagnostic criteria, BED involves:

• Eating an unusually large amount of food in a discrete period
• Feeling a lack of control during these episodes
• Experiencing marked distress about the binge eating
• Binge eating at least once a week for three months
• The absence of regular compensatory behaviors (like purging or excessive exercise)

Left untreated, BED can lead to serious health complications including obesity, type 2 diabetes, heart disease, and mental health challenges like depression and anxiety. The good news? Effective treatments exist—and many are now accessible through telehealth.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Regulations: What You Need to Know

Non-Controlled Medications: No Federal Barriers

Here’s the most important thing to understand: medications like Topamax (topiramate) and Wellbutrin (bupropion)—commonly used off-label for BED—are not controlled substances. This means they were never subject to the strict federal telehealth restrictions outlined in the Ryan Haight Act.

The Ryan Haight Act, passed in 2008, requires an in-person medical evaluation before prescribing controlled substances (like stimulants or opioids) via telemedicine. However, this law does not apply to non-controlled prescription medications. For BED treatments using non-controlled drugs, telehealth prescribing has always been permissible under federal law, as long as the prescriber is licensed in your state and follows appropriate standards of care.

Temporary Extensions for Controlled Substances

While this guide focuses on non-controlled BED medications, it’s worth noting that the DEA has extended COVID-19 telehealth flexibilities for controlled substances through December 31, 2026. This extension allows certain controlled medications to be prescribed via telehealth without an initial in-person visit, though permanent rules are still being finalized.

For patients seeking BED treatment, this regulatory landscape means access to non-controlled medications like Topamax and Wellbutrin remains fully open nationwide through telehealth in 2026.

State-by-State Telehealth Prescribing Rules

While federal law sets the baseline, individual states have their own telehealth regulations. The good news is that most states have made pandemic-era telehealth flexibilities permanent, especially for non-controlled medications.

States with No In-Person Requirements

The majority of states—including California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina—have no mandatory in-person visit requirement for prescribing non-controlled medications via telehealth. In these states, a thorough telehealth evaluation (typically via video consultation) is considered equivalent to an in-person exam, as long as it meets the standard of care.

California even went a step further in 2025 with AB 1503, which explicitly recognized asynchronous telehealth (such as detailed online questionnaires combined with secure messaging) as a valid form of patient evaluation for certain medications.

States Requiring Periodic In-Person Follow-Ups

A few states have rules requiring periodic in-person visits for ongoing telehealth care:

Alabama requires an in-person visit within 12 months if you’ve had more than four telehealth visits for the same condition. However, this visit can be completed by any collaborating provider in your care network, not necessarily your telehealth prescriber.

Georgia requires an attempt at an in-person exam at least annually for continued telemedicine treatment, though initial evaluations can be done entirely via telehealth if the technology used is equivalent to an in-person exam.

New Hampshire recently updated its laws (effective August 2025) to allow telehealth prescribing even for some controlled substances, with a requirement for an in-person follow-up within 12 months for those medications. For non-controlled BED medications, the rules are more flexible.

What This Means for You

If you live in a state with periodic in-person requirements, you can still start your BED treatment entirely online. The in-person visit, when required, typically comes later in your treatment journey and can often be satisfied by visiting any local healthcare provider who can document a basic exam.

At Klarity Health, we make this process seamless by working with a network of licensed providers across all 50 states, ensuring you can access care regardless of where you live—and we’ll guide you through any state-specific requirements.

Medications for Binge Eating Disorder: What’s Available via Telehealth

While Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for BED, it’s a controlled substance with stricter telehealth limitations. Fortunately, two non-controlled medications have shown effectiveness in treating BED and are widely prescribed via telehealth: Topamax (topiramate) and Wellbutrin (bupropion).

Topamax (Topiramate)

What it is: Topamax is an anticonvulsant medication FDA-approved for seizures and migraine prevention. It’s commonly prescribed off-label for BED due to its ability to reduce binge eating episodes and support impulse control.

How it works for BED: Research suggests that topiramate may help reduce the frequency and severity of binge eating episodes, possibly by affecting neurotransmitters involved in appetite regulation and impulse control. Some patients also experience modest weight loss.

Typical dosing: Treatment usually starts at a low dose (25mg) and is gradually increased over several weeks to minimize side effects. Effective doses for BED typically range from 50-200mg daily.

Key considerations:

• Pregnancy risk: Topiramate is associated with birth defects, including cleft palate, when taken during pregnancy. If you’re of childbearing potential, your provider will discuss effective contraception.
• Cognitive effects: Some people experience ‘brain fog’ or difficulty finding words, especially at higher doses.
• Gradual discontinuation: Never stop topiramate abruptly, as this can increase seizure risk. Your provider will create a tapering schedule if you decide to discontinue.

Telehealth access: Topiramate can be prescribed via telehealth in all 50 states without an initial in-person visit. Prescriptions typically allow for 90-day supplies with refills.

Wellbutrin (Bupropion)

What it is: Wellbutrin is an atypical antidepressant FDA-approved for major depressive disorder and smoking cessation. It’s increasingly used off-label for BED, particularly when depression or emotional eating are present.

How it works for BED: Bupropion affects dopamine and norepinephrine pathways, which may help reduce food cravings and binge urges. Studies have shown it can decrease binge eating frequency in some patients.

Typical dosing: Starting doses range from 150mg once daily (extended-release formulation), potentially increasing to 300mg or 450mg daily depending on response and tolerability.

Key considerations:

• Seizure risk: Wellbutrin lowers the seizure threshold and is contraindicated in people with current or past eating disorders involving purging (bulimia or anorexia) due to electrolyte imbalances that further increase seizure risk. It’s also contraindicated if you have a seizure disorder.
• Black box warning: Like all antidepressants, bupropion carries a warning about increased risk of suicidal thoughts in people under 25. Close monitoring is essential, especially when starting treatment.
• Alcohol interaction: Avoid alcohol while taking Wellbutrin, as this combination significantly increases seizure risk.
• Blood pressure: Bupropion can elevate blood pressure, so monitoring is recommended, especially if you have hypertension.

Telehealth access: Bupropion is available via telehealth nationwide with no in-person requirement. Prescriptions can include refills for up to one year.

Who Can Prescribe BED Medications via Telehealth?

The answer depends on your state, but generally, medical doctors (MDs), doctors of osteopathy (DOs), nurse practitioners (NPs), and physician assistants (PAs) can all prescribe non-controlled BED medications via telehealth.

Nurse Practitioner and Physician Assistant Scope of Practice

The landscape for advanced practice providers has evolved significantly in recent years. As of 2026, approximately 34 states plus the District of Columbia grant nurse practitioners Full Practice Authority (FPA), meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

States with recent expansions of NP independence include:

• Michigan (effective 2025, through Public Act 47 of 2023)
• Wisconsin (APRN Modernization Act, effective August 2025)
• Louisiana and Kansas (also joined FPA states in recent years)

In states without FPA, NPs and PAs work under collaborative agreements with physicians. This doesn’t typically affect your care experience—it’s a regulatory requirement that happens behind the scenes. In states like Texas and Florida, your NP can prescribe medications like Wellbutrin or Topamax for BED under these collaborative frameworks.

At Klarity Health, our network includes both independent NPs in FPA states and collaborative teams in other states, ensuring you receive expert care no matter where you live. Our transparent pricing model—with visits starting at $99 for self-pay patients—makes quality mental health care accessible to everyone, and we accept most major insurance plans.

The Telehealth Evaluation Process: What to Expect

Initial Consultation

Your first telehealth appointment for BED will typically last 30-45 minutes and will be comprehensive. Your provider will ask detailed questions about:

• Eating patterns: Frequency and nature of binge episodes, triggers, duration of symptoms
• Mental health history: Depression, anxiety, trauma, other eating disorders
• Medical history: Current medications, past treatments, medical conditions
• Lifestyle factors: Sleep, stress, support systems, diet and exercise habits
• Treatment goals: What you hope to achieve through medication and therapy

Expect your provider to use standardized assessment tools, such as:

• The Eating Disorder Examination Questionnaire (EDE-Q)
• The Binge Eating Scale (BES)
• Depression and anxiety screening questionnaires

Medical Screening and Safety Checks

Before prescribing medication, your provider will screen for contraindications:

For Wellbutrin:

• History of seizures or seizure disorders
• Current or past bulimia or anorexia nervosa
• Conditions that increase seizure risk (brain tumor, severe head trauma, etc.)
• Use of MAO inhibitors or other medications that interact

For Topamax:

• Pregnancy or pregnancy planning (requires discussion of contraception)
• Kidney stones or kidney problems
• Glaucoma
• Metabolic acidosis risk factors

Your provider may request recent lab work (metabolic panel, kidney function tests) or recommend baseline testing before starting treatment.

Documentation and Consent

Legitimate telehealth providers will:

• Verify your identity and location (required by many state laws)
• Document your informed consent for telehealth services
• Explain the off-label use of medications for BED
• Record detailed clinical notes supporting the diagnosis and treatment plan
• Ensure HIPAA-compliant privacy protections

Red flag: If a telehealth service promises a prescription before completing a thorough evaluation, or if the consultation feels rushed and superficial, seek care elsewhere. Quality providers take time to understand your unique situation.

Understanding Off-Label Prescribing for BED

You may wonder why your provider is prescribing a medication ‘off-label’ when it’s approved for other conditions. This is completely legal, common, and often represents the standard of care for BED.

Off-label prescribing means using an FDA-approved medication for a purpose other than its original approved indication. While Vyvanse is the only medication specifically FDA-approved for BED, clinical research supports the use of topiramate and bupropion for this condition. Off-label use is particularly common in psychiatry and is based on:

• Published clinical studies showing effectiveness
• Professional practice guidelines
• Expert consensus and clinical experience
• Individual patient needs when FDA-approved options aren’t suitable

Your provider should clearly explain:

• Why they’re recommending this particular medication
• The evidence supporting its use for BED
• Potential benefits and risks
• Alternative treatment options
• Your right to ask questions and decline

At Klarity Health, our providers practice evidence-based medicine and take time to ensure you understand and feel comfortable with your treatment plan.

Prescription Monitoring Programs (PMPs): Do They Apply to BED Medications?

Most states require prescribers to check the Prescription Monitoring Program (PMP) database before prescribing controlled substances. These databases track controlled medication dispensing to prevent ‘doctor shopping’ and identify potential misuse.

Good news for BED patients: Because Topamax and Wellbutrin are not controlled substances, most states do not mandate PMP checks before prescribing them.

However, responsible telehealth providers may still review the PMP as a safety measure to:

• Identify potential drug interactions
• Ensure you’re not receiving duplicate prescriptions
• Get a complete picture of your medication history
• Check for other medications that might affect treatment decisions

This voluntary check is considered good clinical practice, but it’s not the legal requirement it would be for controlled substances like stimulants or opioids.

Follow-Up Care and Medication Management

Starting a medication for BED is just the beginning of your treatment journey. Expect regular follow-up appointments, especially in the first few months:

Typical Follow-Up Schedule

• 2 weeks after starting: Initial check-in to assess tolerability and side effects
• 1 month: Review effectiveness, adjust dose if needed
• Monthly for the first 3 months: Monitor progress and make adjustments
• Every 2-3 months thereafter: Ongoing management once stable

What Follow-Ups Include

Your provider will assess:

• Reduction in binge eating frequency
• Side effects or tolerability issues
• Weight changes (if relevant to your treatment goals)
• Mood and mental health status
• Need for dose adjustments
• Integration with therapy or other treatments

Refills and Prescription Duration

Because these are non-controlled medications, providers can typically issue prescriptions with refills:

• 90-day supplies are common for established patients
• Refills can be authorized for 6-12 months (depending on state regulations)
• Prescription renewals may require periodic provider visits (every 3-6 months is typical)

Some states with periodic in-person requirements (like Alabama or Georgia) may require an annual in-person visit for continued telehealth prescribing, but this varies by state and can often be completed with any local provider.

Integrating Medication with Comprehensive BED Treatment

While medication can be a powerful tool for reducing binge eating episodes, the most effective treatment for BED is typically multimodal, combining medication with therapy and lifestyle interventions.

Evidence-Based Therapies for BED

Cognitive Behavioral Therapy (CBT) is the gold-standard psychotherapy for BED. It helps you:

• Identify triggers for binge eating
• Develop healthier coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns
• Build skills for emotional regulation

Dialectical Behavior Therapy (DBT) focuses on:

• Mindfulness and present-moment awareness
• Distress tolerance skills
• Emotion regulation techniques
• Interpersonal effectiveness

Interpersonal Psychotherapy (IPT) addresses:

• Relationship conflicts that may trigger binge eating
• Life transitions and role changes
• Grief and loss
• Social isolation

Nutrition Counseling

Working with a registered dietitian who specializes in eating disorders can help you:

• Develop a balanced, non-restrictive eating plan
• Understand hunger and fullness cues
• Reduce food rules and ‘forbidden foods’ that may trigger binges
• Plan meals that support both physical and emotional wellbeing

The Klarity Health Approach

At Klarity Health, we believe in treating the whole person, not just symptoms. While our providers can prescribe medications like Topamax or Wellbutrin when clinically appropriate, they’ll also discuss therapy options, lifestyle modifications, and additional support resources. Our platform makes it easy to access both medication management and therapy through a single, integrated system—with transparent pricing whether you’re using insurance or paying out of pocket.

Safety Concerns and Quality Standards in Telehealth

The rapid expansion of telehealth during the COVID-19 pandemic brought both opportunities and challenges. While most telehealth providers operate ethically and safely, some high-profile cases have highlighted the need for vigilance.

Red Flags to Watch For

Be cautious of telehealth services that:

• Guarantee prescriptions before completing an evaluation
• Conduct extremely brief consultations (5-10 minutes)
• Don’t ask detailed medical history questions
• Skip discussion of therapy or non-medication options
• Pressure you to start medication immediately
• Don’t provide clear information about provider credentials
• Sell medications directly rather than sending prescriptions to licensed pharmacies
• Lack transparent pricing or surprise you with hidden fees

Quality Indicators of Reputable Services

Look for telehealth platforms that:

• Verify your identity and location at the start of visits (required by many states)
• Conduct comprehensive initial evaluations (typically 30+ minutes)
• Employ licensed providers in your state with verifiable credentials
• Use HIPAA-compliant technology for all communications
• Send prescriptions to established pharmacies (not direct medication sales)
• Provide clear consent forms explaining telehealth limitations and privacy practices
• Offer accessible follow-up care and ways to contact providers between visits
• Practice evidence-based medicine with treatment plans tailored to your needs
• Maintain detailed medical records following the same standards as in-person care

Pharmacy Coordination

Legitimate telehealth providers send prescriptions electronically to the pharmacy of your choice—whether that’s a local pharmacy or a reputable mail-order service. You should receive FDA-approved medications in their original manufacturer packaging, with standard pharmacy labels and information.

Never accept medications shipped directly from a telehealth company’s warehouse unless it’s through a licensed pharmacy service clearly identified on their platform.

Who May Not Be a Candidate for Telehealth BED Treatment

While telehealth opens access to BED treatment for many people, certain situations require in-person evaluation or specialized care:

Medical Contraindications

You may not be suitable for telehealth BED medication treatment if you have:

For Wellbutrin:

• Current or history of bulimia or anorexia nervosa (absolute contraindication due to seizure risk)
• Active seizure disorder or conditions that lower seizure threshold
• Severe, uncontrolled hypertension
• Recent MAO inhibitor use (within 14 days)

For Topamax:

• Pregnancy or actively trying to conceive (requires thorough contraception counseling or alternative treatment)
• Severe kidney disease or history of kidney stones
• Narrow-angle glaucoma
• Severe metabolic acidosis

Clinical Complexity Requiring In-Person Care

You may need a higher level of care or in-person evaluation if you have:

• Medical instability requiring urgent intervention (severe electrolyte imbalances, cardiac complications, etc.)
• Severe psychiatric symptoms including active suicidal ideation, psychosis, or severe depression requiring intensive treatment
• Substance use disorders requiring detoxification or specialized addiction treatment
• Co-occurring eating disorders with purging behaviors, severe restriction, or medical complications
• Cognitive or neurological concerns that require physical examination
• Pregnancy or postpartum period (requires specialized care coordination)
• Very complex medication regimens with multiple specialists involved

Age Considerations

While many telehealth platforms treat adults, adolescents and older adults may have special considerations:

• Patients under 18 typically require parental involvement and may need in-person evaluation
• Older adults with multiple medical conditions may benefit from coordinated in-person care
• Wellbutrin’s black-box warning about suicidal thinking is particularly relevant for patients under 25

If you fall into any of these categories, your telehealth provider should either coordinate with in-person specialists or refer you directly to appropriate local care. This isn’t a limitation of telehealth—it’s responsible, patient-centered medicine.

Cost, Insurance, and Access Considerations

Insurance Coverage for Telehealth BED Treatment

Most health insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to pandemic-era policy changes that have been extended or made permanent in many states. Your coverage typically includes:

• Evaluation and management visits with licensed prescribers
• Psychotherapy sessions (individual, group, or family therapy)
• Prescription medications through your pharmacy benefit

However, coverage specifics vary by plan. Questions to ask your insurance provider:

• Is telehealth covered for mental health and eating disorder treatment?
• Are there any limitations on the number of visits?
• What’s my copay or coinsurance for telehealth visits?
• Do I need a referral or prior authorization?
• Are the medications prescribed (Topamax, Wellbutrin) covered on my formulary?

Self-Pay Options

If you don’t have insurance or prefer not to use it, many telehealth platforms offer transparent self-pay pricing. At Klarity Health, we believe in price transparency:

• Initial consultations start at $99 for self-pay patients
• Follow-up visits are competitively priced
• No hidden fees or surprise charges
• Prescription costs vary by pharmacy and medication, but generic versions of both topiramate and bupropion are typically affordable (often $10-30/month)

We accept both insurance and cash pay, giving you flexibility in how you access care.

Medication Costs

Generic options are available for both medications:

• Topiramate (generic Topamax): $10-40/month without insurance
• Bupropion (generic Wellbutrin): $10-30/month without insurance

Using prescription discount cards (like GoodRx, SingleCare, or RxSaver) can further reduce costs if you’re paying out of pocket.

Recent Regulatory Updates and What They Mean for You (2026)

The regulatory landscape for telehealth continues to evolve, mostly affecting controlled substances rather than the non-controlled BED medications discussed here. Still, it’s helpful to understand the broader context.

Federal Developments

In early 2026, the DEA announced its fourth extension of COVID-19 telehealth prescribing flexibilities for controlled substances, maintaining current rules through December 31, 2026. While this primarily affects stimulants and opioids (not relevant for Topamax or Wellbutrin), it signals continued federal commitment to telehealth access.

The DEA is working on permanent telehealth prescribing rules, expected by late 2026, but these will focus on controlled substances. Non-controlled medications like those used for BED remain unaffected by these regulations.

State-Level Changes

Several states updated their telehealth laws in 2025:

New Hampshire (SB 252, effective August 2025) explicitly allowed telehealth prescribing of even Schedule II-IV controlled substances without an initial in-person visit, requiring only an annual in-person follow-up. This modernization makes New Hampshire one of the most telehealth-friendly states.

New York (Final Rule, May 2025) adopted new requirements for an in-person exam before prescribing controlled substances once federal waivers end—but explicitly exempted non-controlled medications, keeping telehealth access open for treatments like BED medications.

Wisconsin (APRN Modernization Act, August 2025) granted nurse practitioners full practice authority, joining about 34 states with independent NP practice. This expands access to qualified prescribers for telehealth BED treatment.

Delaware (SB 101, July 2025) clarified that telemedicine is allowed for medication-assisted treatment of opioid use disorder, resolving previous conflicts—though not directly related to BED, it demonstrates state commitment to telehealth access for addiction and mental health conditions.

What This Means for BED Patients

The trend is clear: telehealth is here to stay, with states and federal authorities working to balance access with safety. For patients seeking BED treatment with non-controlled medications, 2026 offers robust, nationwide access through legitimate telehealth platforms.

Taking the Next Step: How to Access BED Treatment via Telehealth

If you’re ready to explore telehealth treatment for binge eating disorder, here’s how to get started:

1. Choose a Reputable Telehealth Platform

Research platforms that specialize in mental health and eating disorder treatment. Look for:

• Licensed providers in your state
• Transparent pricing
• Comprehensive evaluations (not quick prescription mills)
• Integration of medication and therapy options
• Positive patient reviews and clear credentials

Klarity Health specializes in mental health conditions including eating disorders, with a network of experienced providers across all 50 states. Our platform makes it easy to schedule appointments that fit your schedule—often with availability within days, not weeks.

2. Prepare for Your Initial Consultation

Before your first appointment, gather:

• Medical history: List of current medications, allergies, past treatments
• Symptom documentation: Notes about binge eating frequency, triggers, duration
• Mental health history: Previous diagnoses, therapy, hospitalizations
• Questions: Write down what you want to know about treatment options
• Insurance information: If using insurance, have your card ready

3. Be Honest and Thorough

The quality of your care depends on the quality of information you provide. Be candid about:

• Eating patterns and behaviors
• Mental health symptoms
• Substance use
• Medical conditions
• Pregnancy plans or status
• Concerns about side effects
• Treatment preferences and goals

4. Discuss Treatment Options

A comprehensive BED treatment plan may include:

• Medication (if clinically appropriate)
• Individual therapy (CBT, DBT, or IPT)
• Nutrition counseling
• Support groups
• Lifestyle modifications
• Family involvement (when helpful)

5. Commit to Follow-Through

Starting medication is just the beginning. Successful BED treatment requires:

• Regular follow-up appointments to monitor progress
• Honest communication about side effects and challenges
• Engagement in therapy alongside medication
• Patience as you and your provider find the right approach
• Self-compassion as you navigate recovery

Your Path Forward: BED Treatment is Within Reach

Binge eating disorder is a serious but treatable condition. The expansion of telehealth has removed many barriers that once kept people from accessing evidence-based care—whether that’s geographic isolation, scheduling challenges, or simply the difficulty of finding a specialist.

In 2026, you can confidently pursue BED treatment via telehealth, knowing that:

• Federal and state laws support telehealth prescribing of non-controlled medications
• Experienced providers across the country offer virtual consultations
• Medications like Topamax and Wellbutrin can be legally and safely prescribed online
• Comprehensive treatment integrating medication and therapy is available through one platform
• Quality standards and safety regulations protect patients

At Klarity Health, we’re committed to making mental healthcare accessible, affordable, and effective. Our providers understand eating disorders and take a compassionate, evidence-based approach to treatment. Whether you have insurance or prefer our transparent self-pay pricing, we’re here to help you take the first step toward recovery.

Ready to get started? Visit Klarity Health to schedule your initial consultation with a licensed provider who can evaluate your symptoms and discuss whether medication, therapy, or both might be right for you. With provider availability often within days and appointments that fit your schedule, help is closer than you think.

Citations and Research Currency

Research Currency Statement
Verified as of: January 4, 2026

This article reflects the most current federal and state telehealth regulations as of early 2026, with emphasis on sources published or updated in 2025. Key regulatory statuses were verified through official government sources (DEA, HHS, state medical boards) and legal analyses. Over 80% of citations are from 2025 sources, with 2024 sources used only when confirmed still accurate by newer references.

Top 5 Primary Sources:

1. U.S. Department of Health & Human Services. ‘DEA Extends COVID-19 Telemedicine Prescribing Flexibilities Through December 31, 2026.’ HHS.gov Press Release, January 2, 2026. www.hhs.gov

2. Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog, August 2025. www.sheppardhealthlaw.com

3. Center for Connected Health Policy (CCHP). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing Database.’ Updated November-December 2025. www.cchpca.org

4. Health Jobs Nationwide Blog. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ October 2025. blog.healthjobsnationwide.com

5. DailyMed (National Library of Medicine). ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Prescribing Information.’ Latest label revision, 2025. dailymed.nlm.nih.gov

Additional Key Sources:

• National Law Review coverage of state telehealth legislation (2024-2025)
• State boards of nursing and medicine (TX, CA, NY, NH, WI, MI, and others) for scope-of-practice verification
• Walden Eating Disorders Center for DSM-5 diagnostic criteria
• MotherToBaby (OTIS) for medication pregnancy risk data
• American MedSpa Association for Wisconsin APRN law analysis (2025)

⚠️ Note: Alabama and South Carolina NP scope legislation was discussed in 2025 but final implementation status requires confirmation. Readers in these states should verify current NP practice authority with their state nursing board.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12